Home > °øÁö»çÇ×
 
 
 
 
 
   
Á¦¸ñ
Psoriasis Tissue Model - in vitro Human 3D Model
Á¦¸ñ ¾øÀ½

Psoriasis Tissue Model

Human 3D (NHu-3D) 

Psoriasis Tissue Model
 
NEW Organotypic Model for Pre-clinical Drug Screening!
 
  
  • Human 3D Model of Psoriatic Tissue
  • Fully Differentiated, Ready-To-Use
  • Unsurpassed Tissue Reproducibility
  • Quantifiable, Objective Endpoints
  • Cost Effective Pre-clinical Drug Testing
Attributes
 
Increased Expression of:
  • Ki67
  • HBD2
  • Psoriasis
  • Elafin
  • Calgranulin C
  • Cytokeratin 16
  • And More
Decreased Expression of:
  • Fillagrin
 
Increased Secretion of:
  • IL-6
  • IL-8
  • GM-CSF
  • And More
The Psoriasis Tissue Model is responsive to treatment with anti-psoriatic compounds in a dose dependent manner.  
 
Receive a copy of Technical Reference 702 - Development and Characterization of a 3D Psoriatic Tissue Model here.
            
Drug Discovery, Development, Delivery & Toxicology Tools
Standardized Human 3D in vitro Tissue Models
 

»ó¼¼³»¿ëÀº »ó´ã½Ç·Î ¹®ÀÇ ¹Ù¶ø´Ï´Ù.

 

 ÀÌÀü±Û
Normal Human 3D (NHu-3D) Airway Tissue Model
 ´ÙÀ½±Û
In Vitro Human Airway Models of Asthma and COPD